Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

CMR derived left ventricular septal convexity in carriers of the hypertrophic cardiomyopathy-causing MYBPC3-Q1061X mutation.

Tarkiainen M, Sipola P, Jalanko M, Heliö T, Jääskeläinen P, Kivelä K, Laine M, Lauerma K, Kuusisto J.

Sci Rep. 2019 Apr 11;9(1):5960. doi: 10.1038/s41598-019-42376-7.

2.

Novel electrocardiographic features in carriers of hypertrophic cardiomyopathy causing sarcomeric mutations.

Jalanko M, Heliö T, Mustonen P, Kokkonen J, Huhtala H, Laine M, Jääskeläinen P, Tarkiainen M, Lauerma K, Sipola P, Laakso M, Kuusisto J, Nikus K.

J Electrocardiol. 2018 Nov - Dec;51(6):983-989. doi: 10.1016/j.jelectrocard.2018.07.009. Epub 2018 Jul 17.

PMID:
30497761
3.

Fibrosis and wall thickness affect ventricular repolarization dynamics in hypertrophic cardiomyopathy.

Jalanko M, Väänänen H, Tarkiainen M, Sipola P, Jääskeläinen P, Lauerma K, Laitinen T, Laitinen T, Laine M, Heliö T, Kuusisto J, Viitasalo M.

Ann Noninvasive Electrocardiol. 2018 Nov;23(6):e12582. doi: 10.1111/anec.12582. Epub 2018 Jul 4.

PMID:
29974557
4.

Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy.

Tarkiainen M, Sipola P, Jalanko M, Heliö T, Laine M, Järvinen V, Häyrinen K, Lauerma K, Kuusisto J.

J Cardiovasc Magn Reson. 2016 Jun 4;18(1):33. doi: 10.1186/s12968-016-0250-5.

5.

Left ventricular mechanical dispersion is associated with nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.

Jalanko M, Tarkiainen M, Sipola P, Jääskeläinen P, Lauerma K, Laine M, Nieminen MS, Laakso M, Heliö T, Kuusisto J.

Ann Med. 2016 Sep;48(6):417-427. Epub 2016 Jun 1.

PMID:
27249556
6.

Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting.

Tarkiainen M, Tynjälä P, Vähäsalo P, Lahdenne P.

Rheumatology (Oxford). 2015 Jul;54(7):1170-6. doi: 10.1093/rheumatology/keu457. Epub 2014 Dec 10.

PMID:
25504896
7.

Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.

Tynjälä P, Vähäsalo P, Tarkiainen M, Kröger L, Aalto K, Malin M, Putto-Laurila A, Honkanen V, Lahdenne P.

Ann Rheum Dis. 2011 Sep;70(9):1605-12. doi: 10.1136/ard.2010.143347. Epub 2011 May 28.

PMID:
21623000
8.

Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab.

Tarkiainen M, Tynjälä P, Vähäsalo P, Lahdenne P.

Scand J Rheumatol. 2011 Mar;40(2):150-2. doi: 10.3109/03009742.2010.499878. Epub 2010 Sep 26. No abstract available.

PMID:
20868307

Supplemental Content

Loading ...
Support Center